At the end of the latest market close, Adagio Therapeutics Inc. (ADGI) was valued at $6.02. In that particular session, Stock kicked-off at the price of $6.05 while reaching the peak value of $6.06 and lowest value recorded on the day was $5.72. The stock current value is $5.83.Recently in News on January 12, 2022, Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants and Outlines Initiatives to Address Omicron. Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Adagio Therapeutics Inc. shares are logging -92.60% during the 52-week period from high price, and 4.67% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $5.57 and $78.82.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1788339 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Adagio Therapeutics Inc. (ADGI) recorded performance in the market was -19.70%, having the revenues showcasing -81.03% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 669.40M, as it employees total of 68 workers.
Market experts do have their say about Adagio Therapeutics Inc. (ADGI)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 28.74, with a change in the price was noted -21.81. In a similar fashion, Adagio Therapeutics Inc. posted a movement of -78.91% for the period of last 100 days, recording 4,829,106 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ADGI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Adagio Therapeutics Inc. (ADGI)
Raw Stochastic average of Adagio Therapeutics Inc. in the period of last 50 days is set at 0.35%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.25%. In the last 20 days, the company’s Stochastic %K was 2.63% and its Stochastic %D was recorded 2.13%.
Bearing in mind the latest performance of Adagio Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -19.70%. The shares increased approximately by -10.31% in the 7-day charts and went up by -82.98% in the period of the last 30 days. Common stock shares were lifted by -81.03% during last recorded quarter.